{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:51:19Z","timestamp":1781848279069,"version":"3.54.5"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-064694"],"award-info":[{"award-number":["INV-064694"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-064694"],"award-info":[{"award-number":["INV-064694"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01505-w","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:28:10Z","timestamp":1781839690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rotavirus mucosal immunology: insights and research priorities from an international convening in Liverpool, March 2024"],"prefix":"10.1038","volume":"11","author":[{"given":"Christina","family":"Bronowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikondi A.","family":"Mwendera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D.","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Duncan","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Groome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuzwayo C.","family":"Jere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"1505_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/infdis\/jiae597","volume":"232","author":"E Burnett","year":"2025","unstructured":"Burnett, E. et al. Rotavirus vaccine effectiveness stratified by national-level characteristics: an introduction to the 24-country MNSSTER-V Project, 2007-2023. J. Infect. Dis. 232, 308\u2013315 (2025).","journal-title":"J. Infect. Dis."},{"key":"1505_CR2","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/cid\/civ1013","volume":"62","author":"JE Tate","year":"2016","unstructured":"Tate, J. E., Burton, A. H., Boschi-Pinto, C. & Parashar, U. D. & World Health Organization-Coordinated Global Rotavirus Surveillance, N. Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 62, S96\u2013S105 (2016).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"1505_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger, C. et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis. 18, 1211\u20131228 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"1505_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S1473-3099(17)30276-1","volume":"17","author":"GBDD Collaborators","year":"2017","unstructured":"Collaborators, G. B. D. D. D. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect. Dis. 17, 909\u2013948 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"1505_CR5","volume":"11","author":"H Bergman","year":"2021","unstructured":"Bergman, H. et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst. Rev. 11, CD008521 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1505_CR6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/cid\/ciu564","volume":"59","author":"JE Tate","year":"2014","unstructured":"Tate, J. E. & Parashar, U. D. Rotavirus vaccines in routine use. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 59, 1291\u20131301 (2014).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"1505_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/14760584.2020.1800459","volume":"19","author":"P Pereira","year":"2020","unstructured":"Pereira, P., Vetter, V., Standaert, B. & Benninghoff, B. Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned. Expert Rev. Vaccines 19, 755\u2013769 (2020).","journal-title":"Expert Rev. Vaccines"},{"key":"1505_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJMoa0904797","volume":"362","author":"SA Madhi","year":"2010","unstructured":"Madhi, S. A. et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 362, 289\u2013298 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1505_CR9","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","volume":"376","author":"GE Armah","year":"2010","unstructured":"Armah, G. E. et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376, 606\u2013614 (2010).","journal-title":"Lancet"},{"key":"1505_CR10","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.vaccine.2004.01.044","volume":"22","author":"T Vesikari","year":"2004","unstructured":"Vesikari, T. et al. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine 22, 2836\u20132842 (2004).","journal-title":"Vaccine"},{"key":"1505_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa052664","volume":"354","author":"T Vesikari","year":"2006","unstructured":"Vesikari, T. et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 354, 23\u201333 (2006).","journal-title":"N. Engl. J. Med"},{"key":"1505_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","volume":"376","author":"K Zaman","year":"2010","unstructured":"Zaman, K. et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 376, 615\u2013623 (2010).","journal-title":"Lancet"},{"key":"1505_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1473-3099(14)71060-6","volume":"15","author":"N Bar-Zeev","year":"2015","unstructured":"Bar-Zeev, N. et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Lancet Infect. Dis. 15, 422\u2013428 (2015).","journal-title":"Lancet Infect. Dis."},{"key":"1505_CR14","doi-asserted-by":"publisher","first-page":"126726","DOI":"10.1016\/j.vaccine.2025.126726","volume":"48","author":"HT Aanyu","year":"2025","unstructured":"Aanyu, H. T. et al. Effectiveness of monovalent rotavirus vaccine against hospital-attended rotavirus gastroenteritis among children in Uganda. Vaccine 48, 126726 (2025).","journal-title":"Vaccine"},{"key":"1505_CR15","doi-asserted-by":"publisher","unstructured":"Pitzer, V. E. et al. Evaluating strategies to improve rotavirus vaccine impact during the second year of life in Malawi. Sci. Transl. Med. 11 https:\/\/doi.org\/10.1126\/scitranslmed.aav6419 (2019).","DOI":"10.1126\/scitranslmed.aav6419"},{"key":"1505_CR16","doi-asserted-by":"publisher","first-page":"103122","DOI":"10.1016\/j.eclinm.2025.103122","volume":"81","author":"O Prunas","year":"2025","unstructured":"Prunas, O. et al. Global estimates of rotavirus vaccine efficacy and effectiveness: a rapid review and meta-regression analysis. EClinicalMedicine 81, 103122 (2025).","journal-title":"EClinicalMedicine"},{"key":"1505_CR17","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1086\/605035","volume":"200","author":"M Patel","year":"2009","unstructured":"Patel, M. et al. Oral rotavirus vaccines: how well will they work where they are needed most. J. Infect. Dis. 200, S39\u2013S48 (2009).","journal-title":"J. Infect. Dis."},{"key":"1505_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27074-1","volume":"12","author":"EPK Parker","year":"2021","unstructured":"Parker, E. P. K. et al. Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants. Nat. Commun. 12, 7288 (2021).","journal-title":"Nat. Commun."},{"key":"1505_CR19","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1080\/21645515.2020.1844525","volume":"17","author":"B Lee","year":"2021","unstructured":"Lee, B. Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines. Hum. Vaccin Immunother. 17, 1787\u20131802 (2021).","journal-title":"Hum. Vaccin Immunother."},{"key":"1505_CR20","doi-asserted-by":"publisher","unstructured":"Sharma, S. & Nordgren, J. Effect of infant and maternal secretor status on rotavirus vaccine take-an overview. Viruses 13 (2021). https:\/\/doi.org\/10.3390\/v13061144","DOI":"10.3390\/v13061144"},{"key":"1505_CR21","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/infdis\/jiaa101","volume":"224","author":"FB Williams","year":"2021","unstructured":"Williams, F. B. et al. Maternal secretor status affects oral rotavirus vaccine response in breastfed infants in Bangladesh. J. Infect. Dis. 224, 1147\u20131151 (2021).","journal-title":"J. Infect. Dis."},{"key":"1505_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/cid\/ciy896","volume":"69","author":"I Praharaj","year":"2019","unstructured":"Praharaj, I. et al. Diarrheal etiology and impact of coinfections on rotavirus vaccine efficacy estimates in a clinical trial of a monovalent human-bovine (116E) oral rotavirus vaccine, Rotavac, India. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 69, 243\u2013250 (2019).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"1505_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/infdis\/jiad234","volume":"228","author":"J Mandolo","year":"2023","unstructured":"Mandolo, J. et al. Association between maternal breastmilk microbiota composition and rotavirus vaccine response in African, Asian, and European Infants: A Prospective Cohort Study. J. Infect. Dis. 228, 637\u2013645 (2023).","journal-title":"J. Infect. Dis."},{"key":"1505_CR24","doi-asserted-by":"publisher","first-page":"e1004734","DOI":"10.1371\/journal.pmed.1004734","volume":"22","author":"J Mandolo","year":"2025","unstructured":"Mandolo, J. et al. Maternal-infant rotavirus-specific antibody kinetics to inform timing of vaccine boosting in Malawi: An observational study. PLoS Med. 22, e1004734 (2025).","journal-title":"PLoS Med"},{"key":"1505_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/mi.2014.114","volume":"8","author":"E Clarke","year":"2015","unstructured":"Clarke, E. & Desselberger, U. Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol. 8, 1\u201317 (2015).","journal-title":"Mucosal Immunol."},{"key":"1505_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/infdis\/jit166","volume":"208","author":"M Patel","year":"2013","unstructured":"Patel, M. et al. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J. Infect. Dis. 208, 284\u2013294 (2013).","journal-title":"J. Infect. Dis."},{"key":"1505_CR27","doi-asserted-by":"publisher","first-page":"e1008732","DOI":"10.1371\/journal.ppat.1008732","volume":"16","author":"SL Caddy","year":"2020","unstructured":"Caddy, S. L. et al. Intracellular neutralisation of rotavirus by VP6-specific IgG. PLoS Pathog. 16, e1008732 (2020).","journal-title":"PLoS Pathog."},{"key":"1505_CR28","doi-asserted-by":"publisher","first-page":"e70053","DOI":"10.1002\/mco2.70053","volume":"6","author":"D Xie","year":"2025","unstructured":"Xie, D., Lu, G., Mai, G., Guo, Q. & Xu, G. Tissue-resident memory T cells in diseases and therapeutic strategies. MedComm 6, e70053 (2025).","journal-title":"MedComm"},{"key":"1505_CR29","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJMoa1706804","volume":"378","author":"JE Bines","year":"2018","unstructured":"Bines, J. E. et al. Human neonatal rotavirus vaccine (RV3-BB) to target rotavirus from birth. N. Engl. J. Med. 378, 719\u2013730 (2018).","journal-title":"N. Engl. J. Med"},{"key":"1505_CR30","doi-asserted-by":"publisher","first-page":"eadn4176","DOI":"10.1126\/sciadv.adn4176","volume":"10","author":"EO Asare","year":"2024","unstructured":"Asare, E. O., Al-Mamun, M. A., Armah, G. E., Lopman, B. A. & Pitzer, V. E. Impact of dosing schedules on performance of rotavirus vaccines in Ghana. Sci. Adv. 10, eadn4176 (2024).","journal-title":"Sci. Adv."},{"key":"1505_CR31","doi-asserted-by":"publisher","first-page":"1680448","DOI":"10.3389\/fvets.2025.1680448","volume":"12","author":"W Huo","year":"2025","unstructured":"Huo, W., Qiao, Y., Li, E., Li, M. & Che, L. Interplay between nutrition, microbiota, and immunity in rotavirus infection: insights from human and animal models. Front. Vet. Sci. 12, 1680448 (2025).","journal-title":"Front. Vet. Sci."},{"key":"1505_CR32","unstructured":"Estes, M. K. & Greenberg, H. B. in Fields Virology (ed Howley PM Knipe DM, Cohen JI, Griffin DE, Lamb RA, Martin MA, et al.) 1347\u20131401 (Wolters Kluwer\/Lippincott, Williams and Wilkins, 2013)."},{"key":"1505_CR33","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJM199610033351404","volume":"335","author":"FR Velazquez","year":"1996","unstructured":"Velazquez, F. R. et al. Rotavirus infection in infants as protection against subsequent infections. N. Engl. J. Med. 335, 1022\u20131028 (1996).","journal-title":"N. Engl. J. Med."},{"key":"1505_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJMoa1006261","volume":"365","author":"BP Gladstone","year":"2011","unstructured":"Gladstone, B. P. et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N. Engl. J. Med. 365, 337\u2013346 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1505_CR35","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1053\/j.gastro.2009.02.076","volume":"136","author":"HB Greenberg","year":"2009","unstructured":"Greenberg, H. B. & Estes, M. K. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 136, 1939\u20131951 (2009).","journal-title":"Gastroenterology"},{"key":"1505_CR36","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1086\/317619","volume":"182","author":"FR Velazquez","year":"2000","unstructured":"Velazquez, F. R. et al. Serum antibody as a marker of protection against natural rotavirus infection and disease. J. Infect. Dis. 182, 1602\u20131609 (2000).","journal-title":"J. Infect. Dis."},{"key":"1505_CR37","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1128\/jcm.26.4.732-738.1988","volume":"26","author":"K Grimwood","year":"1988","unstructured":"Grimwood, K. et al. Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children. J. Clin. Microbiol. 26, 732\u2013738 (1988).","journal-title":"J. Clin. Microbiol."},{"key":"1505_CR38","unstructured":"Tewari, T. et al. in MedRxiv (2025)."},{"key":"1505_CR39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/INF.0b013e318290646d","volume":"32","author":"SS Moon","year":"2013","unstructured":"Moon, S. S. et al. Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr. Infect. Dis. J. 32, 863\u2013870 (2013).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1505_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/JVI.01930-15","volume":"90","author":"K Saxena","year":"2016","unstructured":"Saxena, K. et al. Human intestinal enteroids: a new model to study human rotavirus infection, host restriction, and pathophysiology. J. Virol. 90, 43\u201356 (2016).","journal-title":"J. Virol."},{"key":"1505_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/imr.13185","volume":"315","author":"C Tabilas","year":"2023","unstructured":"Tabilas, C., Smith, N. L. & Rudd, B. D. Shaping immunity for life: Layered development of CD8(\u2009+\u2009) T cells. Immunol. Rev. 315, 108\u2013125 (2023).","journal-title":"Immunol. Rev."},{"key":"1505_CR42","doi-asserted-by":"publisher","unstructured":"Knoop, K. A. et al. Microbial antigen encounter during a preweaning interval is critical for tolerance to gut bacteria. Sci. Immunol. 2 https:\/\/doi.org\/10.1126\/sciimmunol.aao1314 (2017).","DOI":"10.1126\/sciimmunol.aao1314"},{"key":"1505_CR43","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41577-023-00890-w","volume":"23","author":"D Ramanan","year":"2023","unstructured":"Ramanan, D. et al. Regulatory T cells in the face of the intestinal microbiota. Nat. Rev. Immunol. 23, 749\u2013762 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1505_CR44","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.immuni.2021.07.005","volume":"54","author":"A Bhattacharjee","year":"2021","unstructured":"Bhattacharjee, A. et al. Environmental enteric dysfunction induces regulatory T cells that inhibit local CD4\u2009+\u2009T cell responses and impair oral vaccine efficacy. Immunity 54, 1745\u20131757 e1747 (2021).","journal-title":"Immunity"},{"key":"1505_CR45","doi-asserted-by":"publisher","unstructured":"Rey, L. M. et al. LAP(+) Cells modulate protection induced by oral vaccination with rhesus rotavirus in a neonatal mouse model. J. Virol. 93 https:\/\/doi.org\/10.1128\/JVI.00882-19 (2019).","DOI":"10.1128\/JVI.00882-19"},{"key":"1505_CR46","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1128\/JVI.79.8.4568-4579.2005","volume":"79","author":"MC Jaimes","year":"2005","unstructured":"Jaimes, M. C., Feng, N. & Greenberg, H. B. Characterization of homologous and heterologous rotavirus-specific T-cell responses in infant and adult mice. J. Virol. 79, 4568\u20134579 (2005).","journal-title":"J. Virol."},{"key":"1505_CR47","doi-asserted-by":"publisher","first-page":"e61101","DOI":"10.1371\/journal.pone.0061101","volume":"8","author":"MS Aiyegbo","year":"2013","unstructured":"Aiyegbo, M. S. et al. Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PloS one 8, e61101 (2013).","journal-title":"PloS one"},{"key":"1505_CR48","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/cid\/ciu633","volume":"59","author":"J Nordgren","year":"2014","unstructured":"Nordgren, J. et al. Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 59, 1567\u20131573 (2014).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"1505_CR49","doi-asserted-by":"publisher","unstructured":"Perez-Ortin, R. et al. Histo-blood group antigens in children with symptomatic rotavirus infection. Viruses 11 (2019). https:\/\/doi.org\/10.3390\/v11040339","DOI":"10.3390\/v11040339"},{"key":"1505_CR50","doi-asserted-by":"publisher","unstructured":"Rakau, K. et al. The association between symptomatic rotavirus infection and histo-blood group antigens in young children with diarrhea in Pretoria, South Africa. Viruses 14 https:\/\/doi.org\/10.3390\/v14122735 (2022).","DOI":"10.3390\/v14122735"},{"key":"1505_CR51","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/cid\/ciy1067","volume":"69","author":"L Pollock","year":"2019","unstructured":"Pollock, L. et al. Nonsecretor Histo-blood Group Antigen Phenotype Is Associated With Reduced Risk of Clinical Rotavirus Vaccine Failure in Malawian Infants. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 69, 1313\u20131319 (2019).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"1505_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/cid\/civ828","volume":"62","author":"SS Moon","year":"2016","unstructured":"Moon, S. S. et al. Prevaccination rotavirus serum IgG and IgA are associated with lower immunogenicity of live, oral human rotavirus vaccine in South African infants. Clin. Infect. Dis. 62, 157\u2013165 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"1505_CR53","doi-asserted-by":"publisher","first-page":"e0189351","DOI":"10.1371\/journal.pone.0189351","volume":"12","author":"K Mwila-Kazimbaya","year":"2017","unstructured":"Mwila-Kazimbaya, K. et al. Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia. PLoS one 12, e0189351 (2017).","journal-title":"PLoS one"},{"key":"1505_CR54","doi-asserted-by":"publisher","first-page":"A134","DOI":"10.1016\/j.vaccine.2014.04.078","volume":"32","author":"T Rongsen-Chandola","year":"2014","unstructured":"Rongsen-Chandola, T. et al. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine 32, A134\u2013A139 (2014).","journal-title":"Vaccine"},{"key":"1505_CR55","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.3945\/jn.116.246090","volume":"147","author":"DR Laucirica","year":"2017","unstructured":"Laucirica, D. R., Triantis, V., Schoemaker, R., Estes, M. K. & Ramani, S. Milk oligosaccharides inhibit human rotavirus infectivity in MA104 Cells. J. Nutr. 147, 1709\u20131714 (2017).","journal-title":"J. Nutr."},{"key":"1505_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-015-0071-z","volume":"3","author":"ZT Lewis","year":"2015","unstructured":"Lewis, Z. T. et al. Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome 3, 13 (2015).","journal-title":"Microbiome"},{"key":"1505_CR57","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1093\/cid\/ciac910","volume":"76","author":"LM Schwartz","year":"2023","unstructured":"Schwartz, L. M. et al. Histo-blood group antigen null phenotypes associated with a decreased risk of clinical rotavirus vaccine failure among children <2 years of age participating in the vaccine impact on diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 76, S153\u2013S161 (2023).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"1505_CR58","doi-asserted-by":"publisher","first-page":"e0145568","DOI":"10.1371\/journal.pone.0145568","volume":"10","author":"A Ali","year":"2015","unstructured":"Ali, A. et al. Correction: Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine-a randomized trial. PLoS ONE 10, e0145568 (2015).","journal-title":"PLoS ONE"},{"key":"1505_CR59","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1016\/j.vaccine.2020.01.097","volume":"38","author":"JA Church","year":"2020","unstructured":"Church, J. A. et al. Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants. Vaccine 38, 2870\u20132878 (2020).","journal-title":"Vaccine"},{"key":"1505_CR60","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3389\/fimmu.2020.00587","volume":"11","author":"SR Lueschow","year":"2020","unstructured":"Lueschow, S. R. & McElroy, S. J. The Paneth cell: the curator and defender of the immature small intestine. Front Immunol. 11, 587 (2020).","journal-title":"Front Immunol."},{"key":"1505_CR61","doi-asserted-by":"publisher","first-page":"2197833","DOI":"10.1080\/19490976.2023.2197833","volume":"15","author":"SA Raev","year":"2023","unstructured":"Raev, S. A., Amimo, J. O., Saif, L. J. & Vlasova, A. N. Intestinal mucin-type O-glycans: the major players in the host-bacteria-rotavirus interactions. Gut Microbes. 15, 2197833 (2023).","journal-title":"Gut Microbes"},{"key":"1505_CR62","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41385-019-0240-7","volume":"13","author":"DH Kulkarni","year":"2020","unstructured":"Kulkarni, D. H. et al. Goblet cell associated antigen passages support the induction and maintenance of oral tolerance. Mucosal Immunol. 13, 271\u2013282 (2020).","journal-title":"Mucosal Immunol."},{"key":"1505_CR63","doi-asserted-by":"publisher","first-page":"e0131624","DOI":"10.1128\/mbio.01316-24","volume":"15","author":"GO Adeniyi-Ipadeola","year":"2024","unstructured":"Adeniyi-Ipadeola, G. O. et al. Infant and adult human intestinal enteroids are morphologically and functionally distinct. mBio. 15, e0131624 (2024).","journal-title":"mBio"},{"key":"1505_CR64","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.immuni.2023.03.002","volume":"56","author":"MAA Sikder","year":"2023","unstructured":"Sikder, M. A. A. et al. Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection. Immunity 56, 1098\u20131114 e1010 (2023).","journal-title":"Immunity"},{"key":"1505_CR65","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/mi.2016.79","volume":"10","author":"T Sun","year":"2017","unstructured":"Sun, T. et al. Intestinal Batf3-dependent dendritic cells are required for optimal antiviral T-cell responses in adult and neonatal mice. Mucosal Immunol. 10, 775\u2013788 (2017).","journal-title":"Mucosal Immunol."},{"key":"1505_CR66","doi-asserted-by":"publisher","first-page":"e2250085","DOI":"10.1002\/eji.202250085","volume":"53","author":"L Reusch","year":"2023","unstructured":"Reusch, L. & Angeletti, D. Memory B-cell diversity: from early generation to tissue residency and reactivation. Eur. J. Immunol. 53, e2250085 (2023).","journal-title":"Eur. J. Immunol."},{"key":"1505_CR67","doi-asserted-by":"publisher","unstructured":"Lim, A. I. et al. Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring. Science 373 https:\/\/doi.org\/10.1126\/science.abf3002 (2021).","DOI":"10.1126\/science.abf3002"},{"key":"1505_CR68","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41385-020-0309-3","volume":"14","author":"I Uddback","year":"2021","unstructured":"Uddback, I. et al. Long-term maintenance of lung resident memory T cells is mediated by persistent antigen. Mucosal Immunol. 14, 92\u201399 (2021).","journal-title":"Mucosal Immunol."},{"key":"1505_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30913-4","volume":"13","author":"A Ssemaganda","year":"2022","unstructured":"Ssemaganda, A. et al. Expansion of cytotoxic tissue-resident CD8(\u2009+\u2009) T cells and CCR6(\u2009+\u2009)CD161(\u2009+\u2009) CD4(\u2009+\u2009) T cells in the nasal mucosa following mRNA COVID-19 vaccination. Nat. Commun. 13, 3357 (2022).","journal-title":"Nat. Commun."},{"key":"1505_CR70","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.4161\/hv.29199","volume":"10","author":"SN Desai","year":"2014","unstructured":"Desai, S. N., Cravioto, A., Sur, D. & Kanungo, S. Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines. Hum. Vaccin Immunother. 10, 1457\u20131465 (2014).","journal-title":"Hum. Vaccin Immunother."},{"key":"1505_CR71","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fmicb.2013.00375","volume":"4","author":"C Lutz","year":"2013","unstructured":"Lutz, C., Erken, M., Noorian, P., Sun, S. & McDougald, D. Environmental reservoirs and mechanisms of persistence of Vibrio cholerae. Front. Microbiol. 4, 375 (2013).","journal-title":"Front. Microbiol."},{"key":"1505_CR72","doi-asserted-by":"publisher","first-page":"1155751","DOI":"10.3389\/fmed.2023.1155751","volume":"10","author":"DA Montero","year":"2023","unstructured":"Montero, D. A. et al. Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development. Front. Med. 10, 1155751 (2023).","journal-title":"Front. Med."},{"key":"1505_CR73","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","volume":"17","author":"Q Bi","year":"2017","unstructured":"Bi, Q. et al. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 17, 1080\u20131088 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"1505_CR74","doi-asserted-by":"publisher","unstructured":"Bourque, D. L. et al. Analysis of the human mucosal response to cholera reveals sustained activation of innate immune signaling pathways. Infect Immun. 86 https:\/\/doi.org\/10.1128\/IAI.00594-17 (2018).","DOI":"10.1128\/IAI.00594-17"},{"key":"1505_CR75","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1128\/CVI.00647-15","volume":"23","author":"A Aktar","year":"2016","unstructured":"Aktar, A. et al. O-specific polysaccharide-specific memory b cell responses in young children, older children, and adults infected with Vibrio cholerae O1 Ogawa in Bangladesh. Clin. Vaccin. Immunol. 23, 427\u2013435 (2016).","journal-title":"Clin. Vaccin. Immunol."},{"key":"1505_CR76","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1128\/CVI.00196-12","volume":"19","author":"M Arifuzzaman","year":"2012","unstructured":"Arifuzzaman, M. et al. Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin. Vaccin. Immunol. 19, 1304\u20131311 (2012).","journal-title":"Clin. Vaccin. Immunol."},{"key":"1505_CR77","doi-asserted-by":"publisher","first-page":"e3076","DOI":"10.1371\/journal.pntd.0003076","volume":"8","author":"DT Leung","year":"2014","unstructured":"Leung, D. T. et al. Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. PLoS Negl. Trop. Dis. 8, e3076 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1505_CR78","doi-asserted-by":"publisher","unstructured":"Charles, R. C. et al. Humans surviving cholera develop antibodies against Vibrio cholerae O-specific polysaccharide that inhibit pathogen motility. mBio. 11 https:\/\/doi.org\/10.1128\/mBio.02847-20 (2020).","DOI":"10.1128\/mBio.02847-20"},{"key":"1505_CR79","doi-asserted-by":"publisher","unstructured":"Kauffman, R. C. et al. Impact of immunoglobulin isotype and epitope on the functional properties of Vibrio cholerae O-specific polysaccharide-specific monoclonal antibodies. mBio. 12 https:\/\/doi.org\/10.1128\/mBio.03679-20 (2021).","DOI":"10.1128\/mBio.03679-20"},{"key":"1505_CR80","doi-asserted-by":"publisher","first-page":"101508","DOI":"10.1016\/j.eclinm.2022.101508","volume":"50","author":"YA Lai","year":"2022","unstructured":"Lai, Y. A., Chen, X., Kunasekaran, M., Rahman, B. & MacIntyre, C. R. Global epidemiology of vaccine-derived poliovirus 2016-2021: a descriptive analysis and retrospective case-control study. EClinicalMedicine 50, 101508 (2022).","journal-title":"EClinicalMedicine"},{"key":"1505_CR81","doi-asserted-by":"publisher","first-page":"A85","DOI":"10.1016\/j.vaccine.2022.03.013","volume":"41","author":"A Voorman","year":"2023","unstructured":"Voorman, A. et al. Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine. Vaccine 41, A85\u2013A92 (2023).","journal-title":"Vaccine"},{"key":"1505_CR82","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1093\/cid\/ciy603","volume":"67","author":"EB Brickley","year":"2018","unstructured":"Brickley, E. B. et al. Intestinal immunity to poliovirus following sequential trivalent inactivated polio vaccine\/bivalent oral polio vaccine and trivalent inactivated polio vaccine-only immunization schedules: analysis of an open-label, randomized, controlled trial in Chilean infants. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 67, S42\u2013S50 (2018).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"1505_CR83","doi-asserted-by":"publisher","first-page":"e001613","DOI":"10.1136\/bmjgh-2019-001613","volume":"4","author":"EB Brickley","year":"2019","unstructured":"Brickley, E. B. et al. Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden. BMJ Glob. Health 4, e001613 (2019).","journal-title":"BMJ Glob. Health"},{"key":"1505_CR84","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/infdis\/jiaa783","volume":"226","author":"EB Brickley","year":"2022","unstructured":"Brickley, E. B. et al. Intestinal antibody responses to 2 novel live attenuated type 2 oral poliovirus vaccines in healthy adults in Belgium. J. Infect. Dis. 226, 287\u2013291 (2022).","journal-title":"J. Infect. Dis."},{"key":"1505_CR85","doi-asserted-by":"publisher","first-page":"e1023","DOI":"10.1093\/infdis\/jiae264","volume":"230","author":"A Godin","year":"2024","unstructured":"Godin, A. et al. Nasal and pharyngeal mucosal immunity to poliovirus in children following routine immunization with inactivated polio vaccine in the United States. J. Infect. Dis. 230, e1023\u2013e1030 (2024).","journal-title":"J. Infect. Dis."},{"key":"1505_CR86","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1146\/annurev-immunol-051116-052206","volume":"35","author":"PJM Openshaw","year":"2017","unstructured":"Openshaw, P. J. M., Chiu, C., Culley, F. J. & Johansson, C. Protective and Harmful Immunity to RSV Infection. Annu. Rev. Immunol. 35, 501\u2013532 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"1505_CR87","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1086\/315834","volume":"182","author":"S Choo","year":"2000","unstructured":"Choo, S., Zhang, Q., Seymour, L., Akhtar, S. & Finn, A. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants. J. Infect. Dis. 182, 1260\u20131263 (2000).","journal-title":"J. Infect. Dis."},{"key":"1505_CR88","doi-asserted-by":"publisher","first-page":"1649 e1641","DOI":"10.1016\/j.cmi.2022.07.004","volume":"28","author":"JP Carr","year":"2022","unstructured":"Carr, J. P. et al. Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme. Clin. Microbiol. Infect. 28, 1649 e1641\u20131649 e1648 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"1505_CR89","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jconrel.2022.08.016","volume":"350","author":"JG Edmans","year":"2022","unstructured":"Edmans, J. G. et al. Electrospun patch delivery of anti-TNFalpha F(ab) for the treatment of inflammatory oral mucosal disease. J. Control Release 350, 146\u2013157 (2022).","journal-title":"J. Control Release"},{"key":"1505_CR90","doi-asserted-by":"publisher","unstructured":"Sterlin, D. et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 13 https:\/\/doi.org\/10.1126\/scitranslmed.abd2223 (2021).","DOI":"10.1126\/scitranslmed.abd2223"},{"key":"1505_CR91","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/COH.0b013e3283504941","volume":"7","author":"LR McKinnon","year":"2012","unstructured":"McKinnon, L. R. & Kaul, R. Quality and quantity: mucosal CD4\u2009+\u2009T cells and HIV susceptibility. Curr. Opin. HIV AIDS 7, 195\u2013202 (2012).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"1505_CR92","doi-asserted-by":"publisher","unstructured":"Kochina, E. A. et al. Double and triple combinations of broadly neutralizing antibodies provide efficient neutralization of all HIV-1 strains from the global panel. Viruses 14 https:\/\/doi.org\/10.3390\/v14091910 (2022).","DOI":"10.3390\/v14091910"},{"key":"1505_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39292-w","volume":"14","author":"D Follmann","year":"2023","unstructured":"Follmann, D. et al. Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration. Nat. Commun. 14, 3605 (2023).","journal-title":"Nat. Commun."},{"key":"1505_CR94","doi-asserted-by":"publisher","first-page":"100897","DOI":"10.1016\/S2666-5247(24)00129-0","volume":"5","author":"G Kwatra","year":"2024","unstructured":"Kwatra, G. et al. B Streptococcus colonisation in mother-newborn dyads in low-income and middle-income south Asian and African countries: a prospective, observational study. Lancet Microbe. 5, 100897 (2024). Prevalence of group.","journal-title":"Lancet Microbe"},{"key":"1505_CR95","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1093\/cid\/cix658","volume":"65","author":"NJ Russell","year":"2017","unstructured":"Russell, N. J. et al. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 65, S100\u2013S111 (2017).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"1505_CR96","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/infdis\/jiw056","volume":"213","author":"G Kwatra","year":"2016","unstructured":"Kwatra, G. et al. Serotype-specific cell-mediated immunity associated with clearance of homotypic group B Streptococcus rectovaginal colonization in pregnant women. J. Infect. Dis. 213, 1923\u20131926 (2016).","journal-title":"J. Infect. Dis."},{"key":"1505_CR97","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa2116045","volume":"389","author":"SA Madhi","year":"2023","unstructured":"Madhi, S. A. et al. Potential for maternally administered vaccine for infant group B Streptococcus. N. Engl. J. Med. 389, 215\u2013227 (2023).","journal-title":"N. Engl. J. Med"},{"key":"1505_CR98","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1016\/S1473-3099(18)30659-5","volume":"19","author":"K Le Doare","year":"2019","unstructured":"Le Doare, K. et al. Serocorrelates of protection against infant group B streptococcus disease. Lancet Infect. Dis. 19, e162\u2013e171 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"1505_CR99","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41586-022-05626-9","volume":"614","author":"AG Soerens","year":"2023","unstructured":"Soerens, A. G. et al. Functional T cells are capable of supernumerary cell division and longevity. Nature 614, 762\u2013766 (2023).","journal-title":"Nature"},{"key":"1505_CR100","doi-asserted-by":"publisher","unstructured":"Szabo, P. A., Miron, M. & Farber, D. L. Location, location, location: Tissue resident memory T cells in mice and humans. Sci. Immunol. 4 https:\/\/doi.org\/10.1126\/sciimmunol.aas9673 (2019).","DOI":"10.1126\/sciimmunol.aas9673"},{"key":"1505_CR101","doi-asserted-by":"publisher","unstructured":"Heeg, M. & Goldrath, A. W. License to kill: Retinoic acid programs T cells for tissue residency. J. Exp. Med. 220 https:\/\/doi.org\/10.1084\/jem.20230161 (2023).","DOI":"10.1084\/jem.20230161"},{"key":"1505_CR102","doi-asserted-by":"publisher","unstructured":"Corrado, M. & Pearce, E. L. Targeting memory T cell metabolism to improve immunity. J. Clin. Investig. 132 https:\/\/doi.org\/10.1172\/JCI148546 (2022).","DOI":"10.1172\/JCI148546"},{"key":"1505_CR103","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41586-020-2425-3","volume":"585","author":"T Teratani","year":"2020","unstructured":"Teratani, T. et al. The liver-brain-gut neural arc maintains the T(reg) cell niche in the gut. Nature 585, 591\u2013596 (2020).","journal-title":"Nature"},{"key":"1505_CR104","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41590-024-01773-5","volume":"25","author":"KA Tran","year":"2024","unstructured":"Tran, K. A. et al. Author Correction: BCG immunization induces CX3CR1(hi) effector memory T cells to provide cross-protection via IFN-gamma-mediated trained immunity. Nat. Immunol. 25, 578 (2024).","journal-title":"Nat. Immunol."},{"key":"1505_CR105","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1016\/j.cell.2022.10.006","volume":"185","author":"F Baharom","year":"2022","unstructured":"Baharom, F. et al. Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment. Cell 185, 4317\u20134332 e4315 (2022).","journal-title":"Cell"},{"key":"1505_CR106","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41586-020-03146-y","volume":"590","author":"C Adaken","year":"2021","unstructured":"Adaken, C. et al. Ebola virus antibody decay-stimulation in a high proportion of survivors. Nature 590, 468\u2013472 (2021).","journal-title":"Nature"},{"key":"1505_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41928-2","volume":"13","author":"KJ Roper","year":"2023","unstructured":"Roper, K. J. et al. Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera. Sci. Rep. 13, 15014 (2023).","journal-title":"Sci. Rep."},{"key":"1505_CR108","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jim.2017.12.003","volume":"454","author":"T Liechti","year":"2018","unstructured":"Liechti, T. et al. Development of a high-throughput bead based assay system to measure HIV-1 specific immune signatures in clinical samples. J. Immunol. Methods 454, 48\u201358 (2018).","journal-title":"J. Immunol. Methods"},{"key":"1505_CR109","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","volume":"19","author":"MO Mohsen","year":"2022","unstructured":"Mohsen, M. O. & Bachmann, M. F. Virus-like particle vaccinology, from bench to bedside. Cell Mol. Immunol. 19, 993\u20131011 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"1505_CR110","doi-asserted-by":"publisher","first-page":"e105167","DOI":"10.1371\/journal.pone.0105167","volume":"9","author":"KC Jere","year":"2014","unstructured":"Jere, K. C., O\u2019Neill, H. G., Potgieter, A. C. & van Dijk, A. A. Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa. PloS one 9, e105167 (2014).","journal-title":"PloS one"},{"key":"1505_CR111","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.virol.2009.06.011","volume":"391","author":"MJ Stax","year":"2009","unstructured":"Stax, M. J. et al. Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4(\u2009+\u2009) T-lymphocytes. Virology 391, 203\u2013211 (2009).","journal-title":"Virology"},{"key":"1505_CR112","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.cell.2020.11.019","volume":"183","author":"M Buggert","year":"2020","unstructured":"Buggert, M. et al. The identity of human tissue-emigrant CD8(\u2009+\u2009) T Cells. Cell 183, 1946\u20131961 e1915 (2020).","journal-title":"Cell"},{"key":"1505_CR113","doi-asserted-by":"publisher","unstructured":"Mvaya, L. et al. Differential localization and limited cytotoxic potential of duodenal CD8\u2009+\u2009T cells. JCI Insight 7 https:\/\/doi.org\/10.1172\/jci.insight.154195 (2022).","DOI":"10.1172\/jci.insight.154195"},{"key":"1505_CR114","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jcmgh.2018.06.010","volume":"6","author":"SE Blutt","year":"2018","unstructured":"Blutt, S. E. The Next MacGyver: a platform to study intestinal organoids using high-throughput computer-driven microinjection. Cell Mol. Gastroenterol. Hepatol. 6, 352\u2013353 (2018).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1505_CR115","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1172\/JCI128382","volume":"129","author":"N Feng","year":"2019","unstructured":"Feng, N. et al. Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells. J. Clin. Investig. 129, 3839\u20133851 (2019).","journal-title":"J. Clin. Investig."},{"key":"1505_CR116","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1164\/rccm.201212-2277OC","volume":"187","author":"DM Ferreira","year":"2013","unstructured":"Ferreira, D. M. et al. Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am. J. Respir. Crit. Care Med. 187, 855\u2013864 (2013).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"1505_CR117","doi-asserted-by":"publisher","first-page":"e1002622","DOI":"10.1371\/journal.ppat.1002622","volume":"8","author":"AK Wright","year":"2012","unstructured":"Wright, A. K. et al. Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage. PLoS Pathog. 8, e1002622 (2012).","journal-title":"PLoS Pathog."},{"key":"1505_CR118","doi-asserted-by":"publisher","first-page":"e0284399","DOI":"10.1371\/journal.pone.0284399","volume":"18","author":"RE Robinson","year":"2023","unstructured":"Robinson, R. E. et al. Comprehensive review of safety in experimental human pneumococcal challenge. PloS one 18, e0284399 (2023).","journal-title":"PloS one"},{"key":"1505_CR119","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1164\/rccm.201503-0542OC","volume":"192","author":"AM Collins","year":"2015","unstructured":"Collins, A. M. et al. First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial. Am. J. Respir. Crit. Care Med. 192, 853\u2013858 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1505_CR120","doi-asserted-by":"publisher","first-page":"e683","DOI":"10.1016\/S2666-5247(23)00178-7","volume":"4","author":"D Dula","year":"2023","unstructured":"Dula, D. et al. Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study. Lancet Microbe. 4, e683\u2013e691 (2023).","journal-title":"Lancet Microbe"},{"key":"1505_CR121","doi-asserted-by":"publisher","first-page":"e062109","DOI":"10.1136\/bmjopen-2022-062109","volume":"12","author":"K Liatsikos","year":"2022","unstructured":"Liatsikos, K. et al. Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2. BMJ Open 12, e062109 (2022).","journal-title":"BMJ Open"},{"key":"1505_CR122","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1164\/rccm.201811-2081LE","volume":"199","author":"J Rylance","year":"2019","unstructured":"Rylance, J. et al. Two randomized trials of the effect of live attenuated influenza vaccine on pneumococcal colonization. Am. J. Respir. Crit. Care Med. 199, 1160\u20131163 (2019).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"1505_CR123","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.chom.2024.07.024","volume":"32","author":"E Mitsi","year":"2024","unstructured":"Mitsi, E. et al. RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding. Cell Host Microbe. 32, 1608\u20131620 e1604 (2024).","journal-title":"Cell Host Microbe"},{"key":"1505_CR124","first-page":"7357","volume":"38","author":"R Chilengi","year":"2020","unstructured":"Chilengi, R. et al. A pilot study on use of live attenuated rotavirus. Vaccin. (Rotarix) Infect. Chall. model. Vaccin. 38, 7357\u20137362 (2020).","journal-title":"Vaccin. (Rotarix) Infect. Chall. model. Vaccin."},{"key":"1505_CR125","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jcmgh.2016.11.007","volume":"3","author":"DR Hill","year":"2017","unstructured":"Hill, D. R. & Spence, J. R. Gastrointestinal Organoids: Understanding the Molecular Basis of the Host-Microbe Interface. Cell Mol. Gastroenterol. Hepatol. 3, 138\u2013149 (2017).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1505_CR126","doi-asserted-by":"publisher","unstructured":"Sanchez-Tacuba, L. et al. An optimized reverse genetics system suitable for efficient recovery of simian, human, and murine-like rotaviruses. J. Virol. 94 https:\/\/doi.org\/10.1128\/JVI.01294-20 (2020).","DOI":"10.1128\/JVI.01294-20"},{"key":"1505_CR127","doi-asserted-by":"publisher","first-page":"e0070622","DOI":"10.1128\/jvi.00706-22","volume":"96","author":"P Doldan","year":"2022","unstructured":"Doldan, P. et al. Type III and not Type I interferons efficiently prevent the spread of rotavirus in human intestinal epithelial cells. J. Virol. 96, e0070622 (2022).","journal-title":"J. Virol."},{"key":"1505_CR128","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.1073\/pnas.1100552108","volume":"108","author":"J Pott","year":"2011","unstructured":"Pott, J. et al. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. USA. 108, 7944\u20137949 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1505_CR129","doi-asserted-by":"publisher","unstructured":"Reyes, A. et al. Impact of hypoxia over human viral infections and key cellular processes. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22157954 (2021).","DOI":"10.3390\/ijms22157954"},{"key":"1505_CR130","doi-asserted-by":"publisher","first-page":"e2214421120","DOI":"10.1073\/pnas.2214421120","volume":"120","author":"T Kawagishi","year":"2023","unstructured":"Kawagishi, T. et al. Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses. Proc. Natl. Acad. Sci. USA. 120, e2214421120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1505_CR131","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1586\/14760584.2014.953939","volume":"14","author":"Z Dangor","year":"2015","unstructured":"Dangor, Z., Kwatra, G., Izu, A., Lala, S. G. & Madhi, S. A. B Streptococcus capsular antibody and protection against invasive disease in infants. Expert Rev. Vaccines 14, 135\u2013149 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"1505_CR132","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41590-023-01722-8","volume":"25","author":"M Takahama","year":"2024","unstructured":"Takahama, M. et al. A pairwise cytokine code explains the organism-wide response to sepsis. Nat. Immunol. 25, 226\u2013239 (2024).","journal-title":"Nat. Immunol."},{"key":"1505_CR133","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205\u20131211 (2021).","journal-title":"Nat. Med."},{"key":"1505_CR134","doi-asserted-by":"publisher","first-page":"eabq0839","DOI":"10.1126\/science.abq0839","volume":"377","author":"AA Cohen","year":"2022","unstructured":"Cohen, A. A. et al. Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models. Science 377, eabq0839 (2022).","journal-title":"Science"},{"key":"1505_CR135","doi-asserted-by":"publisher","first-page":"1273938","DOI":"10.3389\/fimmu.2023.1273938","volume":"14","author":"SHE Kaufmann","year":"2023","unstructured":"Kaufmann, S. H. E. Vaccine development against tuberculosis before and after Covid-19. Front. Immunol. 14, 1273938 (2023).","journal-title":"Front. Immunol."},{"key":"1505_CR136","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41590-022-01329-5","volume":"23","author":"S Fourati","year":"2022","unstructured":"Fourati, S. et al. Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination. Nat. Immunol. 23, 1777\u20131787 (2022).","journal-title":"Nat. Immunol."},{"key":"1505_CR137","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41577-023-00854-0","volume":"23","author":"BF Haynes","year":"2023","unstructured":"Haynes, B. F. et al. Author Correction: Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies. Nat. Rev. Immunol. 23, 265 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1505_CR138","doi-asserted-by":"publisher","first-page":"310rv317","DOI":"10.1126\/scitranslmed.aac7732","volume":"7","author":"L Corey","year":"2015","unstructured":"Corey, L. et al. Immune correlates of vaccine protection against HIV-1 acquisition. Sci. Transl. Med 7, 310rv317 (2015).","journal-title":"Sci. Transl. Med"},{"key":"1505_CR139","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1172\/JCI126391","volume":"129","author":"SD Neidich","year":"2019","unstructured":"Neidich, S. D. et al. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk. J. Clin. Investig. 129, 4838\u20134849 (2019).","journal-title":"J. Clin. Investig."},{"key":"1505_CR140","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1038\/s41591-022-01953-6","volume":"28","author":"PB Gilbert","year":"2022","unstructured":"Gilbert, P. B. et al. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition. Nat. Med. 28, 1924\u20131932 (2022).","journal-title":"Nat. Med."},{"key":"1505_CR141","doi-asserted-by":"publisher","unstructured":"Pulendran, B. & Davis, M. M. The science and medicine of human immunology. Science 369 https:\/\/doi.org\/10.1126\/science.aay4014 (2020).","DOI":"10.1126\/science.aay4014"},{"key":"1505_CR142","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2217\/fmb-2017-0128","volume":"13","author":"EP Parker","year":"2018","unstructured":"Parker, E. P. et al. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol. 13, 97\u2013118 (2018).","journal-title":"Future Microbiol."},{"key":"1505_CR143","doi-asserted-by":"crossref","unstructured":"Jiang, V., Jiang, B., Tate, J., Parashar, U. D. & Patel, M. M. Performance of rotavirus vaccines in developed and developing countries. Hum. Vaccin. 6 (2010). 11278 [pii]","DOI":"10.4161\/hv.6.7.11278"},{"key":"1505_CR144","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1473-3099(18)30602-9","volume":"19","author":"JA Church","year":"2019","unstructured":"Church, J. A., Parker, E. P., Kirkpatrick, B. D., Grassly, N. C. & Prendergast, A. J. Interventions to improve oral vaccine performance: a systematic review and meta-analysis. Lancet Infect. Dis. 19, 203\u2013214 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"1505_CR145","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/cid\/ciw346","volume":"63","author":"ER Colgate","year":"2016","unstructured":"Colgate, E. R. et al. Delayed dosing of oral rotavirus vaccine demonstrates decreased risk of rotavirus gastroenteritis associated with serum zinc: a randomized controlled trial. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 63, 634\u2013641 (2016).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"1505_CR146","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/bies.201100093","volume":"33","author":"WA McEwan","year":"2011","unstructured":"McEwan, W. A., Mallery, D. L., Rhodes, D. A., Trowsdale, J. & James, L. C. Intracellular antibody-mediated immunity and the role of TRIM21. Bioessays 33, 803\u2013809 (2011).","journal-title":"Bioessays"},{"key":"1505_CR147","doi-asserted-by":"publisher","first-page":"8205","DOI":"10.1016\/j.vaccine.2011.08.059","volume":"29","author":"H Okayasu","year":"2011","unstructured":"Okayasu, H., Sutter, R. W., Czerkinsky, C. & Ogra, P. L. Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission. Vaccine 29, 8205\u20138214 (2011).","journal-title":"Vaccine"},{"key":"1505_CR148","doi-asserted-by":"publisher","first-page":"S732","DOI":"10.1093\/infdis\/jiab497","volume":"224","author":"AS Iyer","year":"2021","unstructured":"Iyer, A. S. & Harris, J. B. Correlates of protection for Cholera. J. Infect. Dis. 224, S732\u2013S737 (2021).","journal-title":"J. Infect. Dis."},{"key":"1505_CR149","doi-asserted-by":"publisher","first-page":"e0254278","DOI":"10.1371\/journal.pone.0254278","volume":"16","author":"EM Kunda-Ngandu","year":"2021","unstructured":"Kunda-Ngandu, E. M. et al. Exploring willingness to participate in future Human Infection Studies in Lusaka, Zambia: A nested qualitative exploratory study. PloS one 16, e0254278 (2021).","journal-title":"PloS one"},{"key":"1505_CR150","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.soh.2024.100086","volume":"3","author":"C Chu","year":"2024","unstructured":"Chu, C. et al. Trends in epidemiological characteristics and etiologies of diarrheal disease in children under five: an ecological study based on Global Burden of Disease study 2021. Sci. One Health 3, 100086 (2024).","journal-title":"Sci. One Health"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01505-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01505-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01505-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:03:33Z","timestamp":1781845413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01505-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01505-w","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}